Option Care Health, Inc.
Financials
Valuation Metrics
Option Care Health, Inc.'s Market Cap is $3.82B. At end of 2025 it was $5.04B. Ranked #1549 of 3,121 in US market (top 50%), #541 of 1,463 on NASDAQ (top 37%), #94 of 205 in Health Care Equipment & Services (top 46%) by Market Cap.
Investment Metrics(as of 2026-09-19)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $3.82B | US#1,549/3,121 Sec#94/205 |
| Revenue | $5.69B | US#818/3,121 Sec#47/205 |
| Net Income | $210M | US#1,272/3,121 Sec#61/205 |
| Total Assets | $3.38B | US#1,734/3,121 Sec#81/205 |
| Net Assets | $1.26B | US#1,614/3,121 Sec#87/205 |
| Employees | 6,528 | US#1,080/3,121 Sec#79/205 |
| Value | ||
| P/E | 18.21x | US#1,016/3,121 Sec#20/205 |
| P/B | 3.03x | US#1,768/3,121 Sec#96/205 |
| P/S | 0.67x | US#456/3,121 Sec#35/205 |
| EV/EBITDA | 11.77x | US#1,117/3,121 Sec#34/205 |
| FCF Yield | 9.09% | US#717/3,121 Sec#30/205 |
| Profitability | ||
| ROE | 16.63% | US#778/3,121 Sec#34/205 |
| ROA | 6.20% | US#883/3,121 Sec#57/205 |
| Op. Margin | 5.94% | US#1,915/3,121 Sec#102/205 |
| Revenue Growth | 5.95% | US#1,709/3,121 Sec#123/205 |
| Earnings Growth | -0.79% | US#1,315/3,121 Sec#72/205 |
| Financial Health | ||
| Debt Ratio | 168.18% | US#1,622/3,121 Sec#139/205 |
| Total Debt | $1.27B | US#1,417/3,121 Sec#76/205 |
| FCF | $347M | US#1,080/3,121 Sec#63/205 |
| Cash | $194M | US#1,755/3,121 Sec#104/205 |
| Current Ratio | 1.47x | US#1,709/3,121 Sec#151/205 |
| Net Debt/EBITDA | 2.59x | US#1,490/3,121 Sec#90/205 |
| Performance | ||
| 1Y Return | -14.47% | US#2,203/3,121 Sec#149/205 |
| 1M Return | 4.07% | US#514/3,121 Sec#63/205 |
| From 52W High | -33.97% | US#2,226/3,121 Sec#149/205 |
| 1Y MDD | -46.65% | US#2,313/3,121 Sec#141/205 |
| Trading | ||
| Volume | 5,045,155 shares | US#509/3,121 Sec#24/205 |
| Trading Value | $122M | US#955/3,121 Sec#75/205 |
| Per Share | ||
| EPS | $1.33 | US#1,574/3,121 Sec#81/205 |
| BPS | $8.02 | US#2,003/3,121 Sec#117/205 |
Company Info
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.